Showing results (61-70 of 202) with videos related to
Sort By:
Pageof 21
Clinical Pharmacology and Therapeutics|December 17, 2009
Evaluation and management of cardiac safety using the electrocardiogram in oncology clinical trials: focus on cardiac repolarization (QTc interval)J Morganroth, R R Shah, J W ScottAnnals of Internal Medicine|September 1, 1976
Cholestyramine: an effective, twice-daily dosage regimenC B Blum, R J Havlik, J MorganrothClinical Cardiology|July 1, 1981
Large Mobile pedunculated left ventricular thrombus: identification by two-dimensional echocardiographyC C Chen, G W Webster, J MorganrothCirculation|October 1, 1989
Mechanisms and risk factors for proarrhythmia with type Ia compared with Ic antiarrhythmic drug therapyJ H Levine, J Morganroth, A H KadishClinical Therapeutics|January 1, 1986
Oral antiarrhythmic agents for ventricular arrhythmiasM D Meissner, P F Nestico, J MorganrothAnnals of Internal Medicine|September 1, 1985
Tocainide: a new oral antiarrhythmic agentS P Kutalek, J Morganroth, L N HorowitzAnnals of Internal Medicine|June 1, 1980
Nonsustained ventricular tachycardia in ambulatory patients: characteristics and association with sudden cardiac deathW P Follansbee, E L Michelson, J MorganrothAmerican Heart Journal|October 1, 1985
A review of the uses and limitations of tocainide--a class IB antiarrhythmic agentJ Morganroth, P F Nestico, L N HorowitzCirculation|June 1, 1983
Effect of propranolol on ventricular arrhythmia. The beta-blocker heart attack trial experienceE Lichstein, J Morganroth, R Harrist, et al.The American Journal of Cardiology|June 1, 1977
Electrocardiographic left atrial enlargement. Electrophysiologic, echocardiographic and hemodynamic correlatesM E Josephson, J A Kastor, J MorganrothPageof 21